Clinical Trials Browser

Phase 4 × Lymphoma, Large B-Cell, Diffuse × apatinib × Clear all

NCT03376958 2019-07-25

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

Phase 4 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse